Thorpe S J, Turner C E, Heath A C, Sands D
Division of Haematology, National Institute for Biological Standards and Control (NIBSC), Potters Bar, UK.
Vox Sang. 2000;79(2):100-7. doi: 10.1159/000031220.
The batch control of anti-D immunoglobulin for prevention of haemolytic disease of the newborn necessitates assessment of its potency. Anti-D quantitation is usually performed using automated haemagglutination methodology although this can only be carried out in specialist centres. The aim of this study was to develop a simple and robust assay for anti-D quantitation.
We developed a competitive enzyme-linked immunoassay (EIA) in which unlabelled anti-D immunoglobulin and a biotinylated monoclonal anti-D compete for red cell binding. Binding of biotinylated anti-D is detected using an alkaline-phosphatase-labelled avidin preparation. The assay is conveniently carried out using erythrocytes fixed to microtitre plates.
The competitive EIA was specific for anti-D activity, highly reproducible and showed good correlation with manufacturers' potency estimates using automated haemagglutination. The assay was quick and simple to perform using freshly prepared or stored plates, and the biotinylated monoclonal anti-D could be lyophilized in ampoules for distribution as a standardized reagent.
The competitive EIA described can be used for the specific quantitation of anti-D and provides a robust alternative method to automated haemagglutination.
为预防新生儿溶血病而进行的抗-D免疫球蛋白批量控制需要对其效价进行评估。抗-D定量通常采用自动血凝方法进行,不过这只能在专业中心开展。本研究的目的是开发一种简单且可靠的抗-D定量检测方法。
我们开发了一种竞争性酶联免疫吸附测定法(EIA),其中未标记的抗-D免疫球蛋白和生物素化的抗-D单克隆抗体竞争与红细胞结合。使用碱性磷酸酶标记的抗生物素蛋白制剂检测生物素化抗-D的结合情况。该检测使用固定在微量滴定板上的红细胞方便地进行。
竞争性EIA对抗-D活性具有特异性,重复性高,并且与使用自动血凝法的制造商效价估计值具有良好的相关性。使用新鲜制备或储存的板进行该检测快速且简单,并且生物素化的抗-D单克隆抗体可以冻干在安瓿中作为标准化试剂分发。
所描述的竞争性EIA可用于抗-D的特异性定量,并为自动血凝提供了一种可靠的替代方法。